AlphaCentric Advisors »

Arbutus Biopharma shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $231k 48k 4.81

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Two Seas Capital
Vanguard Group
State Street Corporation
ADAR1 Capital Management
Adage Capital Partners GP
Geode Capital Management
Woodline Partners
BlackBarn Capital Partners
Rubric Capital Management
Charles Schwab Investment Management
Advisor Group Holdings
Northern Trust
Stempoint Capital

View all funds holding Arbutus Biopharma